Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemical Recurrent Prostate Cancer”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Testing effectiveness (Phase 2)Looking for participantsNCT04700332
What this trial is testing

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 184
Large-scale testing (Phase 3)Study completedNCT02578940
What this trial is testing

Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer

Who this might be right for
Cancer of the Prostate
Blue Earth Diagnostics 104
Large-scale testing (Phase 3)Study completedNCT00439751
What this trial is testing

Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy

Who this might be right for
Prostate Cancer
Ontario Clinical Oncology Group (OCOG) 79
Not applicableStudy completedNCT06604377
What this trial is testing

Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features

Who this might be right for
Prostate Cancer
Ruijin Hospital 203
Testing effectiveness (Phase 2)Active Not RecruitingNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Not applicableEnded earlyNCT04234399
What this trial is testing

Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy

Who this might be right for
Prostatic Neoplasm
University of Vermont 22
Testing effectiveness (Phase 2)Ended earlyNCT00670046
What this trial is testing

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04206319
What this trial is testing

Radium-223 in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemical Recurrent Prostate Cancer
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT04838613
What this trial is testing

Study of Diagnostic Performance of [18F]CTT1057 in BCR

Who this might be right for
Prostatic NeoplasmsProstate CancerRecurrence
Novartis Pharmaceuticals 190
Large-scale testing (Phase 3)Active Not RecruitingNCT04302454
What this trial is testing

Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy

Who this might be right for
Prostate Cancer
University Medical Center Groningen 280
Large-scale testing (Phase 3)Looking for participantsNCT04423211
What this trial is testing

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+1 more
ECOG-ACRIN Cancer Research Group 804
Testing effectiveness (Phase 2)Active Not RecruitingNCT03444844
What this trial is testing

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
Five Eleven Pharma, Inc. 60
Large-scale testing (Phase 3)Study completedNCT03739684
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more
Progenics Pharmaceuticals, Inc. 208
Not applicableLooking for participantsNCT06941363
What this trial is testing

Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence

Who this might be right for
Prostate Cancer (Post Prostatectomy)
University of Milano Bicocca 50
Testing effectiveness (Phase 2)Study completedNCT03515577
What this trial is testing

Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery

Who this might be right for
Recurrent Prostate Carcinoma
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00669656
What this trial is testing

Herbal Therapy for Treatment of Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Southern California 43
Large-scale testing (Phase 3)UnknownNCT04734184
What this trial is testing

A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Curium PET France 217
Not applicableUnknownNCT04239742
What this trial is testing

F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Radboud University Medical Center 50
Large-scale testing (Phase 3)Looking for participantsNCT05781217
What this trial is testing

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

Who this might be right for
Prostate CancerSalvage RadiotherapyBiochemical Recurrence+2 more
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic 534
Large-scale testing (Phase 3)Study completedNCT02624518
What this trial is testing

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Andrei Iagaru 122
Load More Results